Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
Organ-on-a-chip academic research is in its blossom. Drug toxicity evaluation is a promising area in which organ-on-a-chip technology can apply. A unique advantage of organ-on-a-chip is the ability to integrate drug metabolism and drug toxic processes in a single device, which facilitates evaluation of toxicity of drug metabolites. Human organ-on-a-chip has been fabricated and used to assess drug toxicity with data correlation with the clinical trial. In this review, we introduced the microfluidic chip models of liver, kidney, heart, nerve, and other organs and multiple organs, highlighting the application of these models in drug toxicity detection. Some biomarkers of toxic injury that have been used in organ chip platforms or have potential for use on organ chip platforms are summarized. Finally, we discussed the goals and future directions for drug toxicity evaluation based on organ-on-a-chip technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 A liver chip system for drug toxicity testing. (A) Specific cell type (human, dog, rat) four-cell culture chip used for drug toxicity test [66]; (B) Perfusion-incubator-liver-chip (PIC) using CO2 gas pressure to drive the perfusion medium, which can be used for chronic toxicity repeated dose drug toxicity tests [67] (C) Liver chip combined with fluorescent probe to track mitochondrial function status in real time to monitor cell viability and metabolic function [68]; (D) Liver chip microdevice with a vascular layer, which is helpful for predicting the mechanism of drug liver toxicity at the microcirculation level [69].](https://figures.cochat.ai/paper-figures/dab1891c2b4447f58d4d5cc748a08042/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-1.jpg)
![Figure 2 A kidney chip system for drug toxicity testing. (A) Design of the human kidney proximal tubule-on-a-chip [77]. (B) Microfluidic device designs for single channel and multi-channel devices, and the final device assembly with notable features marked [81]. (C) Design for the device contains the glomerulus, Bowman’s capsule, proximal renal lumen, and capillary tubules [86].](https://figures.cochat.ai/paper-figures/c3c8407e79f44c1cae50f1fc8fd9a69c/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-2.jpg)
![Figure 3 A heart chip system for drug toxicity testing. (A) Schematic of the first microfluidic devices to CMs anisotropy [91]. (B) Representative tissues in the Biowire II platform [96]. (C) Design of the microfluidic device used for integrated heart/cancer-on-a-chip (iHCC) [98].](https://figures.cochat.ai/paper-figures/7595a99fc7424696b3930f8161f217c4/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-3.jpg)
![Figure 4 Schematic diagram of the research progress of neural chips. (A) The structure of the human brain organoid-on-a-chip to model prenatal nicotine exposure [112]. (B) Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer’s disease [114]. (C) A 3D microfluidic device to quantify orientational regeneration of injured neurons in AD by natural product concentration gradients [115].](https://figures.cochat.ai/paper-figures/65c715c882604f6c8a32d3946543047e/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-4.jpg)
![Figure 5 Some other-organ-on-a-chip systems for drug toxicity testing. (A) Schematic representation of the 3-lane OrganoPlate gut-on-a-chip model [122]. (B) A microengineered model of human pulmonary edema [127]. (C) Schematic drawing of the preparation of the in vitro blood–brain barrier (BBB) model [132].](https://figures.cochat.ai/paper-figures/40fc30dd7ccb419cb11c9b1436a0558f/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To solve this problem, researchers developed multiorgan-on-a-chip systems to evaluate the efficacy and off-target toxicity of anticancer therapeutics.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“reconstructed critical functional alveolar-capillary interface in vitro, and they set two lateral micro-chambers into a microfluidic device to simulate pressure-driven stretching of the lungs during breathing [126].”
MethodBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · cited 1×
“Also, it can regulate the oxygenation level, shear stress guarantees the barrier integrity of the cell layer, and it can control cell migration in vitro [5].”
BackgroundKim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 1×
“Through appropriate growth factor treatment, stem cell differentiation and self-organization into organ-specific cell types and tissues occurs, recreating the structure and function of organs in vitro [10].”
BackgroundCirculating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149 · cited 1×
“miRNA-122, miRNA-192 [26] Genomic markers √”
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 2×
“(B) A microengineered model of human pulmonary edema [127].”
BackgroundBiowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952 · cited 1×
“When they contract, they pull the wires to produce a measurable deflection, which is transformed into a heartbeat signature [95].”
BackgroundKim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Maschmeyer, I., Lorenz, A. K., Schimek, K., Hasenberg, T., Ramme, A. P., Hübner, J., Lindner, M., Drewell, C., Bauer, S., Thomas, A., et al. (2015) · Lab on a Chip · doi:10.1039/c5lc00392j · Cited by 861 · cited 1×
“The current research focuses on solving these problems by integrating on-chip analytical techniques such as high-performance liquid chromatography, mass spectrometry, and electrophoresis [100].”
MethodHuman kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849 · cited 2×
“Jang’s group [77] measured the cisplatin toxicity and P-Glycoprotein (P-gp) efflux transporter activity on a human proximal tubule chip.”
BackgroundPark, S. E., Georgescu, A., & Huh, D. (2019) · Science · doi:10.1126/science.aaw7894 · Cited by 847
McGill, M. R., Sharpe, M. R., Williams, C. D., Taha, M., Curry, S. C., & Jaeschke, H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59755 · Cited by 763 · cited 1×
“OCT (ornithine carbamoyltransferase) [23] Early detection biomarker ×”
BackgroundGut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
Kim, H. J., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40126j · Cited by 750 · cited 2×
“Subsequently, this group found that the intestinal villi in the device had particular cell and tissue functions, which were able to secrete mucus and had a robust drug etabolic activity for CYP3A4 [119].”
BackgroundCharacterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Booth, R., & Kim, H. (2012) · Lab on a Chip · doi:10.1039/c2lc40094d · Cited by 739 · cited 2×
“[133] developed a μBBB with a dynamic envir nment of fluid shear stress and a elatively thin two-cell layer interface.”
BackgroundAcute kidney injury-epidemiology, outcomes and economics
Rewa, O., & Bagshaw, S. M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.282 · Cited by 734 · cited 1×
“SCr levels and urine output [29] Diagnostic marker of AKI (acute kidney injury) √”
BackgroundA new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, Á., Tanaka, K., & Niwa, M. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.002 · Cited by 728 · cited 3×
“[132] pr posed a new BBB model, in which primary rat b ain endothelial cells, per cytes, and astrocytes w re co-cultured (Figure 5C).”
BackgroundMethodInfluentialToxicology for the twenty-first century
Hartung, T. (2009) · Nature · doi:10.1038/460208a · Cited by 661 · cited 1×
“Before inception of the liver chip, preclinical determination of drug hepatotoxicity relied on immortalized cell lines and primary isolated hepatocytes (HepG2) [60].”
BackgroundOrgans-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657 · cited 1×
“Although there are still deficiencies in organ size and blood flow conversion [138], this technology has gradually matured.”
BackgroundVatine, G. D., Barrile, R., Workman, M. J., Sances, S., Barriga, B. K., Rahnama, M., Barthakur, S., Kasendra, M., Lucchesi, C., Kerns, J., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.011 · Cited by 632 · cited 2×
“iBMECs form a tight monolayer that expresses cerebrovascular-specific markers [134].”
BackgroundSelf-citationMicrofluidic Devices for Bioapplications
Yeo, L. Y., Chang, H., Chan, P. P. Y., & Friend, J. R. (2011) · Small · doi:10.1002/smll.201000946 · Cited by 622 · cited 1×
“Initially, microfluidic chips were used to replace the traditional analytical method of laboratory analysis by constructing a “μ-TAS” or “lab-on-a-chip” model with microchromatography and capillary electrophoresis [2].”
MethodA liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615 · cited 1×
“In this platform, the spheroids still retain their activity for 30 days, and have proven their potential for drug toxicity assessment [62].”
BackgroundIncidence and Etiology of Drug-Induced Liver Injury in Mainland China
Shen, T., Liu, Y., Shang, J., Xie, Q., Li, J., Yan, M., Xu, J., Niu, J., Liu, J., Watkins, P. B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.002 · Cited by 615
Self-citationChapman, A. B., Devuyst, O., Eckardt, K.-U., Gansevoort, R. T., Harris, T., Horie, S., Kasiske, B. L., Odland, D., Pei, Y., Perrone, R. D., et al. (2015) · Kidney International · doi:10.1038/ki.2015.59 · Cited by 611 · cited 1×
“TFF3 (trefoil factor 3) [37] Early detection biomarker ×”
BackgroundA Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
Zhao, Y., Rafatian, N., Feric, N. T., Cox, B. J., Aschar-Sobbi, R., Wang, E. Y., Aggarwal, P., Zhang, B., Conant, G., Ronaldson-Bouchard, K., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.042 · Cited by 610 · cited 3×
“[96] for the first time use a biodegradable, elastic, UV-polymerizable, and rapid-producing poly(octamethylene maleate (anhydride) citrate) (POMaC) polymer material to create a two-dimensional grid for cell growth, called the Biowire II platform.”
BackgroundMethodInfluentialReproducing human and cross-species drug toxicities using a liver-chip
Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5516 · Cited by 511 · cited 2×
“[66] constructed a human, dog, and rat two-cell and four-cell species-specific liver chip, and used this chip in combination with microscopic observation, fluorescent staining, and biomarker labeling to verify a variety of phenotypes for drug-induced liver injury, correlation between species-specific liver chips and h…”
BackgroundMethodMicrofluidic heart on a chip for higher throughput pharmacological studies
Agarwal, A., Goss, J. A., Cho, A., McCain, M. L., & Parker, K. K. (2013) · Lab on a Chip · doi:10.1039/c3lc50350j · Cited by 494 · cited 2×
“This device reflected the effect of isoprenaline, aβ-adrenergic receptor agonist, on the contractility of ventricular CMs in neonatal rats [46].”
BackgroundHenry, O. Y. F., Villenave, R., Cronce, M. J., Leineweber, W. D., Benz, M. A., & Ingber, D. E. (2017) · Lab on a Chip · doi:10.1039/c7lc00155j · Cited by 482 · cited 8×
“The v li ity of th model was tested by TEER testing.”
InfluentialAnimal Models are Essential to Biological Research: Issues and Perspectives
Barré-Sinoussi, F., & Montagutelli, X. (2015) · Future Science OA · doi:10.4155/fso.15.63 · Cited by 457 · cited 2×
“Animal models have been widely used in the field of pre-clinical testing and toxicity testing of drugs [1].”
BackgroundMethodMarsano, A., Conficconi, C., Lemme, M., Occhetta, P., Gaudiello, E., Votta, E., Cerino, G., Redaelli, A., & Rasponi, M. (2016) · Lab on a Chip · doi:10.1039/c5lc01356a · Cited by 447 · cited 1×
“[94] developed a cardiac chip with hydrocardial coating, which promoted cardiomyocyte maturation through conductive mechanical stimulation, improved electrical stimulation pacing performance, and enabled analysis of cardiac tissue pacing.”
BackgroundMulti-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442 · cited 1×
“Computer simulation of the platform established the flow and provided the physiologically required shear stress [143].”
BackgroundCommercialization of microfluidic devices
Volpatti, L. R., & Yetisen, A. K. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.04.010 · Cited by 432
Gut instincts: Explorations in intestinal physiology and drug delivery
McConnell, E. L., Fadda, H. M., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.012 · Cited by 431 · cited 2×
“The intestine is an essential site for drug etabolis , and ost drugs undergo overall first-pass etabolis in it [116,117].”
BackgroundSung, J. H., & Shuler, M. L. (2009) · Lab on a Chip · doi:10.1039/b901377f · Cited by 431 · cited 1×
“The microfluidic network provides a platform for simulating the pharmacokinetics and pharmacodynamics of drugs in the human body, and the three-dimensional hydrogel provides a tissue environment more similar to physiological requirements [142].”
BackgroundNguyen, D. G., Funk, J., Robbins, J. B., Crogan-Grundy, C., Presnell, S. C., Singer, T., & Roth, A. B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158674 · Cited by 379
Bavli, D., Prill, S., Ezra, E., Levy, G., Cohen, M., Vinken, M., Vanfleteren, J., Jaeger, M., & Nahmias, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522556113 · Cited by 362 · cited 2×
“Changes in mitochondria from oxidative phosphorylation to anaerobic glycolysis indicate impaired mitochondrial function to assess changes in cell viability and metabolic function [68] (Figure 1C).”
BackgroundMethodSkin-on-a-chip model simulating inflammation, edema and drug-based treatment
Wufuer, M., Lee, G., Hur, W., Jeon, B., Kim, B. J., Choi, T. H., & Lee, S. (2016) · Scientific Reports · doi:10.1038/srep37471 · Cited by 356 · cited 1×
“In addition to the organs mentioned above, microfluidic chip models of skin [135], vasculature [136], and tumors [137] are also widely used in drug discovery and preclinical”
BackgroundLiver organoids: from basic research to therapeutic applications
Prior, N., Inacio, P., & Huch, M. (2019) · Gut · doi:10.1136/gutjnl-2019-319256 · Cited by 356 · cited 1×
“The research in this area is still ongoing [75].”
BackgroundThe HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradere, J.-P., Hernandez, C., Gwak, G.-Y., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76887 · Cited by 354
Park, J., Lee, B. K., Jeong, G. S., Hyun, J. K., Lee, C. J., & Lee, S.-H. (2015) · Lab on a Chip · doi:10.1039/c4lc00962b · Cited by 350 · cited 2×
“(B) Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer’s disease [114].”
BackgroundMethodOrgan-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338 · cited 1×
“These models have been proven to have the potential to develop into new platforms for drug toxicity detection [18].”
BackgroundHuman brain organoid-on-a-chip to model prenatal nicotine exposure
Wang, Y., Wang, L., Zhu, Y., & Qin, J. (2018) · Lab on a Chip · doi:10.1039/c7lc01084b · Cited by 325 · cited 2×
“[112] created a microfluidic chip system to culture human-induced pluripotent stem cell (hiPSCs) derived brain organoids in a controlled manner.”
BackgroundSelf-citationThe HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradere, J.-P., Hernandez, C., Gwak, G.-Y., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126975 · Cited by 300 · cited 1×
“Hepatotoxicity HMGB-1 (high-mobility group box 1) [21] Early detection biomarker ×”
Background3D neural tissue models: From spheroids to bioprinting
Zhuang, P., Sun, A. X., An, J., Chua, C. K., & Chew, S. Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.002 · Cited by 270
Maoz, B. M., Herland, A., Henry, O. Y. F., Leineweber, W. D., Yadid, M., Doyle, J., Mannix, R., Kujala, V. J., FitzGerald, E. A., Parker, K. K., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00412e · Cited by 266 · cited 9×
“The v li ity of th model was tested by TEER testing.”
BackgroundInfluentialKostadinova, R., Boess, F., Applegate, D., Suter, L., Weiser, T., Singer, T., Naughton, B., & Roth, A. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.012 · Cited by 262 · cited 2×
“[64] established a nylon scaffold that allows three-dimensional culture of HepG2 and non-parenchymal cells including Kupffer cells, stellate cells, sinusoidal endothelial cells, and bile duct endothelial cells, which can maintain the specific functions of the liver long-term, form bile duct-like structures, and respon…”
BackgroundEwer, M. S., Ali, M. K., Mackay, B., Wallace, S., Valdivieso, M., Legha, S. S., Benjamin, R. S., & Haynie, T. P. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.2.112 · Cited by 244 · cited 1×
“cardiotoxicity LVDP (left ventricular formation pressure) LVSP (left ventricular systolic pressure) [40] Diagnostic marker of myocardial injury √”
BackgroundNanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing
Yang, X., Li, K., Zhang, X., Liu, C., Guo, B., Wen, W., & Gao, X. (2018) · Lab on a Chip · doi:10.1039/c7lc01224a · Cited by 240 · cited 1×
“Yang’s group built a nanofiber membrane-supported lung chip and evaluated the toxicity of gefitinib, an anti-tumor drug targeting epidermal growth factor receptor (EGFR) [128].”
BackgroundSelf-citationChurch, R. J., Kullak‐Ublick, G. A., Aubrecht, J., Bonkovsky, H. L., Chalasani, N., Fontana, R. J., Goepfert, J. C., Hackman, F., King, N. M. P., Kirby, S., et al. (2019) · Hepatology · doi:10.1002/hep.29802 · Cited by 231 · cited 1×
“GST-α (glutathione S-transferase α) [24] Early detection biomarker √”
Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems
Odijk, M., van der Meer, A. D., Levner, D., Kim, H. J., van der Helm, M. W., Segerink, L. I., Frimat, J.-P., Hamilton, G. A., Ingber, D. E., & van den Berg, A. (2015) · Lab on a Chip · doi:10.1039/c4lc01219d · Cited by 209 · cited 2×
“TEER (transendothelial resistance) [38] Biomarker of barrier functions √”
BackgroundA disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice
Wang, L., Tao, T., Su, W., Yu, H., Yu, Y., & Qin, J. (2017) · Lab on a Chip · doi:10.1039/c7lc00134g · Cited by 207 · cited 1×
“Wang’s group [84] constructed a glomerular chip that reconstructed part of the kidney function at the organ level to simulate the”
BackgroundA 3D human lung-on-a-chip model for nanotoxicity testing
Zhang, M., Xu, C., Jiang, L., & Qin, J. (2018) · Toxicology Research · doi:10.1039/c8tx00156a · Cited by 207 · cited 2×
“At the same time, manufactured nanoparticles (NPs) that people come into contact with by inhalation can also cause toxic irritation [125].”
BackgroundMethodMicrofluidic Organ‐on‐a‐Chip Technology for Advancement of Drug Development and Toxicology
Caplin, J. D., Granados, N. G., James, M. R., Montazami, R., & Hashemi, N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500040 · Cited by 205 · cited 1×
“Owing to the existence of species differences, the results obtained from animal models cannot be fully adapted to humans [12].”
BackgroundSaikumar, J., Hoffmann, D., Kim, T.-M., Gonzalez, V. R., Zhang, Q., Goering, P. L., Brown, R. P., Bijol, V., Park, P. J., Waikar, S. S., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs210 · Cited by 201
Development of a Gut-on-a-Chip Model for High Throughput Disease Modeling and Drug Discovery
Beaurivage, C., Naumovska, E., Chang, Y., Elstak, E., Nicolas, A., Wouters, H., van Moolenbroek, G., Lanz, H., Trietsch, S., Joore, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225661 · Cited by 185 · cited 2×
“constructed a high-throughput intestinal chip device to mimic inflammatory bowel disease (IBD) in vitro (Figure 5A) [122].”
BackgroundMethodSchmidt, B. Z., Lehmann, M., Gutbier, S., Nembo, E., Noel, S., Smirnova, L., Forsby, A., Hescheler, J., Avci, H. X., Hartung, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1805-9 · Cited by 182 · cited 1×
“[106] summarized that drug induced neurotoxicity occurs through six pathways, including the blood-brain barrier, lipid-rich structures, energy requirements, synaptic transmission, nerve cell structure, and neurobiochemistry, and toxicological testing methods should include test systems, exposure protocols, test endpoi…”
BackgroundHuman liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity
Chang, S.-Y., Weber, E. J., Sidorenko, V. S., Chapron, A., Yeung, C. K., Gao, C., Mao, Q., Shen, D., Wang, J., Rosenquist, T. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95978 · Cited by 179 · cited 1×
“built a liver–kidney chip model to detect the renal toxicity of aristolochic acid on humans [139].”
BackgroundRiahi, R., Shaegh, S. A. M., Ghaderi, M., Zhang, Y. S., Shin, S. R., Aleman, J., Massa, S., Kim, D., Dokmeci, M. R., & Khademhosseini, A. (2016) · Scientific Reports · doi:10.1038/srep24598 · Cited by 172 · cited 1×
“[72] developed a microfluidic bead electrochemical immunosensor for long-term continuous measurement of cell-secreted biomarkers, which was used in combination with the liver chip to achieve online monitoring of cell-secreted biomarkers, which not only achieved measurement accuracy but also greatly improved detection…”
MethodKidney-based in vitro models for drug-induced toxicity testing
Faria, J., Ahmed, S., Gerritsen, K. G. F., Mihaila, S. M., & Masereeuw, R. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02598-0 · Cited by 168 · cited 1×
“, the liver [13]-, kidney [14]-, heart [15]-, nerves [16]-, and multi-organs-on-chips [17].”
BackgroundSerum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity
Wallace, K. B., Hausner, E., Herman, E., Holt, G. D., Macgregor, J. T., Metz, A. L., Murphy, E., Rosenblum, I. Y., Sistare, F. D., & York, M. J. (2004) · Toxicologic Pathology · doi:10.1080/01926230490261302 · Cited by 158 · cited 1×
“TnI (troponin I) TnT (troponin T) [41] Early detection biomarker ×”
BackgroundBioprinted 3D vascularized tissue model for drug toxicity analysis
Massa, S., Sakr, M. A., Seo, J., Bandaru, P., Arneri, A., Bersini, S., Zare-Eelanjegh, E., Jalilian, E., Cha, B.-H., Antona, S., et al. (2017) · Biomicrofluidics · doi:10.1063/1.4994708 · Cited by 158 · cited 2×
“The device is useful for observing and predicting the mechanism of drug circulation toxicity at the microcirculation level [69] (Figure 1D).”
BackgroundMethodLiver-Kidney-on-Chip To Study Toxicity of Drug Metabolites
Theobald, J., Ghanem, A., Wallisch, P., Banaeiyan, A. A., Andrade-Navarro, M. A., Taškova, K., Haltmeier, M., Kurtz, A., Becker, H., Reuter, S., et al. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00417 · Cited by 157 · cited 1×
“developed a simple liver–kidney chip model in which liver cells stably grow and express related biomarkers [140].”
BackgroundA Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans
Siman, R. G., Toraskar, N., Dang, A., McNeil, E. M., McGarvey, M., Plaum, J., Maloney, E., & Grady, M. S. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2009.0882 · Cited by 156 · cited 1×
“NF-H (neurofilaments heavy subunit) [49] Diagnostic marker of axonal injury ×”
BackgroundHepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016) · Scientific Reports · doi:10.1038/srep35434 · Cited by 156
A Bioprinted Liver-on-a-Chip for Drug Screening Applications
Knowlton, S. M., & Taşoğlu, S. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.05.014 · Cited by 153 · cited 1×
“, the liver [13]-, kidney [14]-, heart [15]-, nerves [16]-, and multi-organs-on-chips [17].”
BackgroundOlfactory cell-based biosensor: A first step towards a neurochip of bioelectronic nose
Liu, Q., Cai, H., Xu, Y., Li, Y., Li, R., & Wang, P. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.01.016 · Cited by 151 · cited 2×
“Qingjun Liu [104] integrated photo-addressable potential sensors on the neurochip, cultured olfactory sensory neurons on it, and fabricated a bioelectronic nose, which expanded the applications of the neural chip.”
MethodMa, C., Zhao, L., Zhou, E.-M., Xu, J., Shen, S., & Wang, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03869 · Cited by 145 · cited 1×
“[65] developed a microfluidic device that mimics the hepatic lobular-like structure.”
The anatomical basis for the immune function of the gut
Pabst, R. (1987) · Anatomy and Embryology · doi:10.1007/bf00310046 · Cited by 137 · cited 1×
“The intestine is an essential site for drug metabolism, and most drugs undergo overall first-pass metabolism in it [116,117].”
BackgroundTau and Axonopathy in Neurodegenerative Disorders
Higuchi, M., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:131 · Cited by 134 · cited 1×
“neurotoxicity plasma P-Tau (phosphorylated-Tau) T-Tau (total Tau) [48] Diagnostic marker of central nervous system (CNS) injury ×”
BackgroundThe Search Continues—An Ideal Marker of GFR
Swan, S. K. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.6.913 · Cited by 133 · cited 1×
“nephrotoxicity GFR (glomerular filtration rate) [28] Diagnostic marker of renal function √”
BackgroundSimultaneous electrical recording of cardiac electrophysiology and contraction on chip
Qian, F., Huang, C., Lin, Y.-D., Ivanovskaya, A. N., O'Hara, T. J., Booth, R. H., Creek, C. J., Enright, H. A., Soscia, D. A., Belle, A. M., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00210f · Cited by 128
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127 · cited 1×
“With the rapid recognition of this issue, people began to discuss good cell culture practice (GCCP) [147] to establish cell quality standards and ensure the integrity and reproducibility of multi-organ chips in vitro.”
BackgroundYu, F., Deng, R., Hao Tong, W., Huan, L., Chan Way, N., IslamBadhan, A., Iliescu, C., & Yu, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13848-5 · Cited by 125
Methods to assess drug permeability across the blood-brain barrier
Nicolazzo, J. A., Charman, S. A., & Charman, W. N. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.3.0001 · Cited by 124 · cited 2×
“[131] in ovated a microfluidic in vitro model of the blood–brain barrier.”
BackgroundEffect of oxygen on breath markers of oxidative stress
Phillips, M., Cataneo, R. N., Greenberg, J., Grodman, R., Gunawardena, R., & Naidu, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.02.00053402 · Cited by 123 · cited 1×
“Breath methylated hydrocarbons [58] Lipid peroxidation markers ×”
BackgroundPharmacokinetic profile that reduces nephrotoxicity of gentamicin in a perfused kidney-on-a-chip
Kim, S., LesherPerez, S. C., Kim, B. C. C., Yamanishi, C., Labuz, J. M., Leung, B., & Takayama, S. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/015021 · Cited by 115 · cited 1×
“[80] cultured Madin-Darby canine kidney (MDCK) cells on a fibronection-coated porous membrane to construct a sandwich structured PDMS chip and used the model to study the kinetics of gentamicin nephrotoxicity.”
MethodIntegrated heart/cancer on a chip to reproduce the side effects of anti-cancer drugs in vitro
Kamei, K.-I., Kato, Y., Hirai, Y., Ito, S., Satoh, J., Oka, A., Tsuchiya, T., Chen, Y., & Tabata, O. (2017) · RSC Advances · doi:10.1039/c7ra07716e · Cited by 113
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies
Ishida, S. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.01.003 · Cited by 106
The transformation in biomarker detection and management of drug‐induced liver injury
Church, R. J., & Watkins, P. B. (2017) · Liver International · doi:10.1111/liv.13441 · Cited by 105 · cited 1×
“K18 (keratin-18) [22] Early detection biomarker √”
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
Tan, L.-L., & Lyon, A. R. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0641-z · Cited by 104 · cited 1×
“MPO (myeloperoxidase) [43] Biomarker of oxidative stress ×”
BackgroundQu, Y., An, F., Luo, Y., Lu, Y., Liu, T., Zhao, W., & Lin, B. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.010 · Cited by 103 · cited 2×
“(C) Design for the device contains the glomerulus, Bowman’s capsule, proximal renal lumen, and capillary tubules [86].”
MethodSelf-citationImpaired Wound Healing of Alveolar Lung Epithelial Cells in a Breathing Lung-On-A-Chip
Felder, M., Trueeb, B., Stucki, A. O., Borcard, S., Stucki, J. D., Schnyder, B., Geiser, T., & Guenat, O. T. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00003 · Cited by 102 · cited 1×
“The main results of these studies will help us to understand the complex pathogenesis of idiopathic pulmonary fibrosis (IPF) [129].”
BackgroundKatagiri, D., Hamasaki, Y., Doi, K., Negishi, K., Sugaya, T., Nangaku, M., & Noiri, E. (2015) · Kidney International · doi:10.1038/ki.2015.327 · Cited by 99
Lescuyer, P., Allard, L., Zimmermann‐Ivol, C. G., Burgess, J. A., Hughes‐Frutiger, S., Burkhard, P. R., Sanchez, J., & Hochstrasser, D. F. (2004) · PROTEOMICS · doi:10.1002/pmic.200300822 · Cited by 96
McAleer, C. W., Pointon, A., Long, C. J., Brighton, R. L., Wilkin, B. D., Bridges, L. R., Narasimhan Sriram, N., Fabre, K., McDougall, R., Muse, V. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45656-4 · Cited by 96 · cited 1×
“The team used a metabolizable liver module to convert terfenadine to fexofenadine to regulate this response [145].”
MethodOn-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Jang, M., Neuzil, P., Volk, T., Manz, A., & Kleber, A. (2015) · Biomicrofluidics · doi:10.1063/1.4922863 · Cited by 95 · cited 1×
“[71] added a phase guide to a 3D perfusion chip without using a pump.”
BackgroundKwon, S. J., Lee, D. W., Shah, D. A., Ku, B., Jeon, S. Y., Solanki, K., Ryan, J. D., Clark, D. S., Dordick, J. S., & Lee, M.-Y. (2014) · Nature Communications · doi:10.1038/ncomms4739 · Cited by 95 · cited 1×
“[73] designed a Team chip that can predict liver toxicity based on metabolism.”
BackgroundHuman iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine
Ellis, B. W., Acun, A., Can, U. I., & Zorlutuna, P. (2017) · Biomicrofluidics · doi:10.1063/1.4978468 · Cited by 94 · cited 2×
“[97] developed a microfluidic device that mimics human myocardium and its surrounding microvasculature by spatially controlling the co-culture of CMs and endothelial cells.”
BackgroundMethodBraña, I., & Tabernero, J. M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq295 · Cited by 93
Müller, T. H. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.797 · Cited by 91 · cited 1×
“HO (heme oxygenase) [56] Biomarker of upper respiratory tract viral infections √”
BackgroundLaminar ventricular myocardium on a microelectrode array-based chip
Kujala, V. J., Pasqualini, F. S., Goss, J. A., Nawroth, J. C., & Parker, K. K. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00324a · Cited by 91 · cited 2×
“[45] constructed a microelectrode array chip based on human pluripotent stem cell-derived cardiomyocytes and a multi-stage array.”
BackgroundBreath biomarkers in diagnosis of pulmonary diseases
Zhou, M., Liu, Y., & Duan, Y. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.07.006 · Cited by 89 · cited 1×
“NOS isoenzymes [55] Breath biomarkers √”
Doherty, K. R., Talbert, D. R., Trusk, P. B., Moran, D. M., Shell, S. A., & Bacus, S. S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.008 · Cited by 88
A Biomimetic Human Gut‐on‐a‐Chip for Modeling Drug Metabolism in Intestine
Guo, Y., Li, Z., Su, W., Wang, L., Zhu, Y., & Qin, J. (2018) · Artificial Organs · doi:10.1111/aor.13163 · Cited by 88 · cited 1×
“alkaline phosphatase (ALP) and stress insensitive (SI) gene expression compared to traditional cell models [121].”
BackgroundNon-invasive electromechanical cell-based biosensors for improved investigation of 3D cardiac models
Caluori, G., Přibyl, J., Pešl, M., Jelínková, Š., Rotrekl, V., Skládal, P., & Raiteri, R. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.10.021 · Cited by 86 · cited 1×
“[93] integrated an electro-mechanical cell biosensor on the heart chip, which could simultaneously detect cardiac excitation–contraction coupling.”
Albumin handling by renal tubular epithelial cells in a microfluidic bioreactor
Ferrell, N., Ricci, K. B., Groszek, J., Marmerstein, J. T., & Fissell, W. H. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24339 · Cited by 83
Micro-engineered perfusable 3D vasculatures for cardiovascular diseases
Menon, N. V., Tay, H. M., Wee, S. N., Li, K. H. H., & Hou, H. W. (2017) · Lab on a Chip · doi:10.1039/c7lc00607a · Cited by 82 · cited 1×
“In addition to the organs mentioned above, microfluidic chip models of skin [135], vasculature [136], and tumors [137] are also widely used in drug discovery and preclinical”
BackgroundHuman kidney on a chip assessment of polymyxin antibiotic nephrotoxicity
Weber, E. J., Lidberg, K. A., Wang, L., Bammler, T. K., MacDonald, J. W., Li, M. J., Redhair, M., Atkins, W. M., Tran, C., Hines, K. M., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123673 · Cited by 81 · cited 1×
“Weber and his team [83] combined the single-channel Norvatis microphysiology system (MPS) and the PTECs to reconstruct the physiological function of human proximal tubules in vitro and used this platform to evaluate the nephrotoxicity of polymyxin antibiotics.”
Methodde Haan, P., Ianovska, M. A., Mathwig, K., van Lieshout, G. A. A., Triantis, V., Bouwmeester, H., & Verpoorte, E. M. J. (2019) · Lab on a Chip · doi:10.1039/c8lc01080c · Cited by 77 · cited 1×
“[123] developed a small cell-free enzymatic digestion system with three microreactors in series to simulate the digestive functions of the mouth, stomach, and small intestine.”
MethodHigh-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model
Conant, G., Lai, B. F. L., Lu, R. X. Z., Korolj, A., Wang, E. Y., & Radisic, M. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9736-2 · Cited by 75 · cited 1×
“, the liver [13]-, kidney [14]-, heart [15]-, nerves [16]-, and multi-organs-on-chips [17].”
BackgroundBreath analysis of hydrogen peroxide as a diagnostic tool
Stolarek, R. A., Białasiewicz, P., Król, M., & Nowak, D. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.031 · Cited by 74
Vlasáková, K., Erdos, Z., Troth, S. P., McNulty, K. A., Chapeau-Campredon, V., Mokrzycki, N., Muniappa, N., Gu, Y., Holder, D., Bailey, W. J., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft330 · Cited by 72 · cited 2×
“NAG (N-acetyl-β-glucosaminidase) [30] Early detection biomarker √”
BackgroundDeng, J., Zhang, X., Chen, Z., Luo, Y., Lu, Y., Liu, T., Wu, Z., Jin, Y., Zhao, W., & Lin, B. (2019) · Biomicrofluidics · doi:10.1063/1.5070088 · Cited by 70 · cited 1×
“[70] constructed a hepatic sinusoidal chip device consisting of four transformed cell lines and perfused it with a peristaltic pump.”
Self-citationKang, W., Giraldo‐Vela, J. P., Nathamgari, S. S. P., McGuire, T. L., McNaughton, R. L., Kessler, J. A., & Espinosa, H. D. (2014) · Lab on a Chip · doi:10.1039/c4lc00721b · Cited by 69 · cited 1×
“[105] integrated microchannels, cell culture chambers, built-in electrodes, and porous substrates in a neurochip that enabled long-term cell culture, differentiation, and transient transfection.”
BackgroundEarly Predictors of Acute Kidney Injury: A Narrative Review
Liu, X., Guan, Y., Xu, S., Li, Q., Sun, Y., Han, R., & Jiang, C. (2016) · Kidney & Blood Pressure Research · doi:10.1159/000447937 · Cited by 66 · cited 1×
“MCP-1 (monocyte chemotactic peptide-1) [33] Early detection biomarker ×”
BackgroundUrinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy
George, B., Joy, M. S., & Aleksunes, L. M. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217745302 · Cited by 66 · cited 1×
“NGAL (neutrophil gelatinase-associated lipocalin) [31] Early detection biomarker √”
BackgroundA human proximal tubule-on-a-chip to study renal disease and toxicity
Sakolish, C. M., Philip, B., & Mahler, G. J. (2019) · Biomicrofluidics · doi:10.1063/1.5083138 · Cited by 66 · cited 2×
“demonstrated that fluid shear stress could promote the proximal tubular epithelial cells (PTECs) to retain more mature phenotypes and develop a glomerulus-on-a-chip model [82].”
BackgroundMethodTheobald, J., Abu el Maaty, M. A., Kusterer, N., Wetterauer, B., Wink, M., Cheng, X., & Wölfl, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40851-9 · Cited by 65 · cited 1×
“Later, the team set up a multi-chamber liver-kidney chip to study drug metabolism in vitro [141].”
BackgroundNierode, G. J., Perea, B. C., McFarland, S. K., Pascoal, J. F., Clark, D. S., Schaffer, D. V., & Dordick, J. S. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.10.001 · Cited by 64 · cited 1×
“[108] described high-throughput screening of human neural progenitor cells using a 3D cell culture chip.”
MethodMicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury
Peplow, P., & Martinez, B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.219025 · Cited by 63 · cited 1×
“miR-425-p, miR-21, miR-93, miR-191, miR-499,miR-328, miR-362-3p, miR-451, miR-486a [50] Genomic markers √”
In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies
Palmiotti, C. A., Prasad, S., Naik, P. U., Kaisar, M. A., Sajja, R. K., Achyuta, A. H., & Cucullo, L. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1464-6 · Cited by 62 · cited 2×
“From a functional and structural point of view, BBB consists of highly differentiated vascular endothelial cells (VECs), which are arranged in the brain microvasculature [130].”
BackgroundSnouber, L. C., Letourneur, F., Chafey, P., Broussard, C., Monge, M., Legallais, C., & Leclerc, E. (2012) · Biotechnology Progress · doi:10.1002/btpr.743 · Cited by 60 · cited 1×
“The LeClerc group [78] established their microfluidic kidney chips to study acrolein and ifosfamide nephrotoxicity.”
MethodZuchowska, A., Kwapiszewska, K., Chudy, M., Dybko, A., & Brzozka, Z. (2017) · ELECTROPHORESIS · doi:10.1002/elps.201600417 · Cited by 56 · cited 1×
“[63] also used 3D spherical culture of HepG2 cells to detect the hepatotoxicity of the anti-cancer drug 5-fluorouracil (5-FU), and found that as the diameter of the sphere increased, HepG2 cells reduced resistance to 5-FU at two test concentrations.”
MethodAssessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip
Li, Z., Guo, Y., Yu, Y., Xu, C., Xu, H., & Qin, J. (2016) · Integrative Biology · doi:10.1039/c6ib00162a · Cited by 54 · cited 1×
“Four cell lines representing liver, tumors (breast and lung cancer), and healthy tissues (stomach cells) were cultured in separate microcavities in multilayer microdevices [144].”
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
Rezaei Kolahchi, A., Khadem Mohtaram, N., Pezeshgi Modarres, H., Mohammadi, M., Geraili, A., Jafari, P., Akbari, M., & Sanati-Nezhad, A. (2016) · Micromachines · doi:10.3390/mi7090162 · Cited by 53
Cardiotoxicity: precision medicine with imprecise definitions
Chung, R., Ghosh, A. K., & Banerjee, A. (2018) · Open Heart · doi:10.1136/openhrt-2018-000774 · Cited by 53 · cited 1×
“Later in the 1970s, it was used to describe cardiac complications caused by anthracycline, adriamycin, and 5-fluorouracil [88].”
BackgroundStructuring a multi-nodal neural network in vitro within a novel design microfluidic chip
van de Wijdeven, R., Ramstad, O. H., Bauer, U. S., Halaas, Ø., Sandvig, A., & Sandvig, I. (2018) · Biomedical Microdevices · doi:10.1007/s10544-017-0254-4 · Cited by 52 · cited 2×
“, the liver [13]-, kidney [14]-, heart [15]-, nerves [16]-, and multi-organs-on-chips [17].”
BackgroundYang, M., & Zhang, X. (2006) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2006.06.071 · Cited by 51
Self-citationAssembly of Hepatocyte Spheroids Using Magnetic 3D Cell Culture for CYP450 Inhibition/Induction
Desai, P., Tseng, H., & Souza, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051085 · Cited by 50 · cited 2×
“CYP (cytochrome P450) [25] Metabolic ability biomarke √”
BackgroundA droplet-chip/mass spectrometry approach to study organic synthesis at nanoliter scale
Beulig, R. J., Warias, R., Heiland, J. J., Ohla, S., Zeitler, K., & Belder, D. (2017) · Lab on a Chip · doi:10.1039/c7lc00313g · Cited by 47 · cited 2×
“Development of microfluidic technology has made the heart chip a new type of in vitro tool, but there are still several core issues that need to be resolved, such as accurate real-time imaging which is difficult to achieve due to the high thickness of the chip and suitable biomarkers [99].”
BackgroundCell- and biomarker-based assays for predicting nephrotoxicity
Huang, J. X., Blaskovich, M. A., & Cooper, M. A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967681 · Cited by 46 · cited 1×
“OPN (osteopontin) [35] Early detection biomarker ×”
Hamilton, L. A., Collins-Yoder, A., & Collins, R. E. (2016) · AACN Advanced Critical Care · doi:10.4037/aacnacc2016953 · Cited by 44 · cited 2×
“ALP (alkalinephosphatase) [19] Diagnostic marker of cholestatic injury √”
BackgroundMechanisms in pulmonary toxicology
Delaunois, L. (2004) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00122-9 · Cited by 43 · cited 1×
“Pulmonary toxicity can be divided into two categories based on the way lungs are exposed to the poison [124].”
BackgroundA novel microfluidic device to model the human proximal tubule and glomerulus
Sakolish, C., & Mahler, G. J. (2017) · RSC Advances · doi:10.1039/c6ra25641d · Cited by 43 · cited 3×
“(B) Microfluidic device designs for single channel and multi-channel devices, and the final device assembly with notable features marked [81].”
BackgroundMethodInfluentialA longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat
Thulin, P., Hornby, R. J., Auli, M., Nordahl, G., Antoine, D. J., Starkey Lewis, P., Goldring, C. E., Park, B. K., Prats, N., Glinghammar, B., et al. (2017) · Biomarkers · doi:10.1080/1354750x.2016.1269131 · Cited by 42 · cited 1×
“GLDH (glutamate dehydrogenase) [20] Early detection biomarker ×”
BackgroundAssessment of cadmium-induced nephrotoxicity using a kidney-on-a-chip device
Li, Z., Jiang, L., Tao, T., Su, W., Guo, Y., Yu, H., & Qin, J. (2017) · Toxicology Research · doi:10.1039/c6tx00417b · Cited by 41 · cited 1×
“[85] cultured primary rat glomerular endothelial cells (GECs) on a microfluidic chip to simulate the selective permeability of the renal barrier and then studied the cadmium-induced nephrotoxicity by detecting the expression of ZO-1 protein by GECs.”
BackgroundElevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
Mikus, M., Drobin, K., Gry, M., Bachmann, J., Lindberg, J., Yimer, G., Aklillu, E., Makonnen, E., Aderaye, G., Roach, J., et al. (2017) · Liver International · doi:10.1111/liv.13174 · Cited by 40 · cited 2×
“FABP1 (fatty acid binding protein 1) [27] Proteomics biomarker ×”
BackgroundImprovement of neural cell adherence to silicon surface by hydroxyl ion implantation
Fan, Y., Cui, F. Z., Chen, L. N., Zhai, Y., & Xu, Q. (2000) · Surface and Coatings Technology · doi:10.1016/s0257-8972(00)00812-4 · Cited by 32 · cited 1×
“[103] directly injected hydroxide ions into the silicon surface, thereby enhancing the hydrophilicity of the silicon surface and promoting cell adhesion.”
Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides
Wang, J., Zhang, X., Li, X., Zhang, Y., Hou, T., Wei, L., Qu, L., Shi, L., Liu, Y., Zou, L., et al. (2016) · Scientific Reports · doi:10.1038/srep24772 · Cited by 32
Self-citationRecent Developments in Microfluidic Chip for in vitro Cell-based Research
Zhuang, Q., Ning, R., Ma, Y., & Lin, J. (2016) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(16)60919-2 · Cited by 28
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
Carr, D. F., Ayehunie, S., Davies, A., Duckworth, C. A., French, S., Hall, N., Hussain, S. A., Mellor, H. R., Norris, A. M., Park, B. K., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.01.002 · Cited by 27 · cited 3×
“DAO (diamine oxidase) Citrulline [54] Biomarker of small intestine injury ×”
BackgroundInfluentialOliver, J., Abbas, K., Lightfoot, J. T., Baskin, K., Collins, B., Wier, D., Bramhall, J. P., Huang, J. H., & Puschett, J. B. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s27921 · Cited by 26
Pianta, T. J., Pickering, J. W., Succar, L., Chin, M. T. M., Davidson, T., Buckley, N. A., Mohamed, F., & Endre, Z. H. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000469715 · Cited by 26 · cited 1×
“CYs C (cystatin C) [34] Early detection biomarker √”
BackgroundJin, D., Ma, X., Luo, Y., Fang, S., Xie, Z., Li, X., Qi, D., Zhang, F., Kong, J., Li, J., et al. (2016) · RSC Advances · doi:10.1039/c6ra01456a · Cited by 23 · cited 1×
“In addition to the organs mentioned above, microfluidic chip models of skin [135], vasculature [136], and tumors [137] are also widely used in drug discovery and preclinical”
BackgroundSelf-citationInnovation for hepatotoxicity in vitro research models: A review
Han, W., Wu, Q., Zhang, X., & Duan, Z. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3711 · Cited by 23 · cited 1×
“Rapid loss of activity and reduced liver specific functions and gene expression are common shortcomings of these models [61].”
BackgroundSelf-citationWu, C., Yang, H., Chien, H., Tseng, M., & Huang, J. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3924-4 · Cited by 20 · cited 1×
“CLU (clusterin) [36] Early detection biomarker ×”
Tang, Y., Qiu, Q., Zhang, F., Xie, M., & Huang, W. (2018) · Lab on a Chip · doi:10.1039/c7lc01143a · Cited by 18 · cited 2×
“[115] designed a microfluidic chip with an asymmetric side channel connected to the central channel by a series of microslots, and built a model of AD neuron damage using 6-OHDA.”
BackgroundMethodRajasingh, S., Isai, D. G., Samanta, S., Zhou, Z., Dawn, B., Kinsey, W. H., Czirók, A., & Rajasingh, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.183 · Cited by 18 · cited 1×
“For example, drug cardiotoxicity can result in cardiac arrhythmias, therefore the preclinical screening of drug cardiotoxicity is crucial [89].”
BackgroundNeural Cell Chip Based Electrochemical Detection of Nanotoxicity
Kafi, M. A., Cho, H., & Choi, J. (2015) · Nanomaterials · doi:10.3390/nano5031181 · Cited by 14 · cited 1×
“[109] grafted a nano-scale film of an arginine–glycine–aspartic acid tripeptide sequence on the surface of the chip for fixation of neurons and facilitated electrochemical measurement.”
BackgroundCirculating microRNAs in Cardiovascular Diseases
Orlicka-Płocka, M., Gurda, D., Fedoruk‐Wyszomirska, A., Smolarek, I., & Wyszko, E. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1334 · Cited by 14 · cited 1×
“miR-146a, miR-1, miR-133, miR-208, miR-499 [44] Genomic markers √”
Causey, M. W., & Singh, N. N. (2014) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2015.01.004 · Cited by 12
A microstructure for interfacing with neurons: the neurochip
Maher, M. P., Wright, J. A., Pine, J., & Tai, Y.-C. (1998) · Proceedings of the 20th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. Vol.20 Biomedical Engineering Towards the Year 2000 and Beyond (Cat. No.98CH36286) · doi:10.1109/iembs.1998.746911 · Cited by 9 · cited 2×
“[101] also designed a chip in which microelectrodes were fabricated to stimulate and detect neuron cells at the same time, using a voltage-sensitive fluorescent dye whose excitation spectrum can change with the membrane potential.”
BackgroundNeurons and Silicon Get Intimate
Service, R. F. (1999) · Science · doi:10.1126/science.284.5414.578 · Cited by 7 · cited 1×
“[102] designed a pattern on the surface of the chip, coated it with a thin layer of diethylenetriamine (DETA) that facilitates the growth of nerve cells.”
BackgroundPrognostic Serum Factors in Patients With Traumatic Brain Injury
Salehpoor, F., Meshkini, A., Razmgiri, A., & Mahdkhah, A. (2016) · Neurosurgery Quarterly · doi:10.1097/wnq.0000000000000117 · Cited by 3 · cited 1×
“SP, sCD40L, TIMP-1, MDA, CK-18 [52] Early detection biomarkers √”
Research works printed but not linked: 3
- Liu, 2011, Study on the changes of the electrical activity of neural networks by nanomaterials based on the microelectrode array neural chip, Tianjin Med. J., 39, 135
- Qu, 2018, Study on neurotoxicity model of SD rat neural stem cell evaluation drug, China Pharm. Aff., 32, 1079
- Zheng, X.N. (2010). Study on Cytotoxicity of Quantum Dots based on Cell Chip Platform. [Master’s Thesis, Fudan University].
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Tumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Microfluidic organ-on-a-chip models of human liver tissue
Moradi, E., Jalili-Firoozinezhad, S., & Solati-Hashjin, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.041 · Cited by 204
Navigating the complexities of drug development for inflammatory bowel disease
Honap, S., Jairath, V., Danese, S., & Peyrin‐Biroulet, L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00953-0 · Cited by 138
“Banked PDOs permit future functional studies, such as toxicity and pharmacokinetic testing, and show considerable promise as future preclinical models in IBD 142–144 .”
Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment
Escher, S. E., Partosch, F., Konzok, S., Jennings, P., Luijten, M., Kienhuis, A. S., de Leeuw, V. C., Reuss, R., Lindemann, K.-M., & Bennekou, S. H. (2022) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2022.en-7341 · Cited by 119
Metadata
- Authors
- Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X.
- Affiliations
- Dalian University of Technology (CN)
- Soochow University (CN)
- Shenzhen University (CN)
- Dalian Institute of Chemical Physics (CN)
- Dalian Medical University (CN)
- Health Science Center, Shenzhen University, Shenzhen 518060, China
- Corresponding author
- Luo, Yong
- Zhang, Xiuli
- Venue
- Micromachines
- Publisher
- MDPI AG
- Published
- 2020-04-03
- Volume
- 11
- Issue
- 4
- Pages
- 381
- ISSN
- 2072-666X (ISSN-L)
- PMC
- PMC7230535
- OpenAlex
- W3014092941
- Cited by
- 140
- References
- 146
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 34 · 2023: 23 · 2022: 21 · 2021: 20 · 2020: 5
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Micromachines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (21675017)
- National Key Research and Development Program of China (2017YFC1702001)
- Shenzhen Fundamental Research and Discipline Layout project (JCYJ2018050815247476)
- China Postdoctoral Science Foundation (21675017)
- Sanming Project of Medicine in Shenzhen (SZSM201612049)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, microfluidic organ models, drug metabolism, multi-organ-on-a-chip, in vitro toxicity testing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.